[CMSB] YoY Annual (Unaudited) Result on 31-Dec-2014 [#4]

Stock
[CMSB] CAHYA MATA SARAWAK BHD
Announcement Date
25-Feb-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
31-Dec-2014 [#4]
Profit Trend
YoY- 26.43%
Quarter Report
Latest QR
Upcoming QR
CMSB's Result
CMSB's Financial Summary
View:
Show?
Annual (Unaudited) Result
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Revenue 1,606,724 1,551,319 1,788,025 1,673,898 1,416,841 1,203,565 1,012,609 7.99%
PBT 332,786 302,139 381,654 341,452 294,894 226,906 178,722 10.90%
Tax -83,767 -84,828 -83,996 -75,844 -79,346 -60,279 -34,233 16.06%
NP 249,019 217,311 297,658 265,608 215,548 166,627 144,489 9.48%
-
NP to SH 215,236 169,177 241,587 221,335 175,072 135,735 120,022 10.21%
-
Tax Rate 25.17% 28.08% 22.01% 22.21% 26.91% 26.57% 19.15% -
Total Cost 1,357,705 1,334,008 1,490,367 1,408,290 1,201,293 1,036,938 868,120 7.73%
-
Net Worth 2,352,883 2,213,213 2,019,826 1,797,959 1,625,576 1,495,298 1,416,758 8.81%
Dividend
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Div 85,950 67,685 48,346 87,831 56,628 55,745 49,421 9.65%
Div Payout % 39.93% 40.01% 20.01% 39.68% 32.35% 41.07% 41.18% -
Equity
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Net Worth 2,352,883 2,213,213 2,019,826 1,797,959 1,625,576 1,495,298 1,416,758 8.81%
NOSH 1,074,375 1,074,375 1,074,375 1,033,309 333,109 327,916 329,478 21.75%
Ratio Analysis
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
NP Margin 15.50% 14.01% 16.65% 15.87% 15.21% 13.84% 14.27% -
ROE 9.15% 7.64% 11.96% 12.31% 10.77% 9.08% 8.47% -
Per Share
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
RPS 149.55 144.39 166.42 161.99 425.34 367.03 307.34 -11.30%
EPS 20.03 15.75 22.69 21.42 17.52 41.39 36.43 -9.48%
DPS 8.00 6.30 4.50 8.50 17.00 17.00 15.00 -9.93%
NAPS 2.19 2.06 1.88 1.74 4.88 4.56 4.30 -10.62%
Adjusted Per Share Value based on latest NOSH - 1,038,841
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
RPS 149.48 144.33 166.35 155.73 131.82 111.98 94.21 7.99%
EPS 20.02 15.74 22.48 20.59 16.29 12.63 11.17 10.20%
DPS 8.00 6.30 4.50 8.17 5.27 5.19 4.60 9.65%
NAPS 2.189 2.0591 1.8792 1.6728 1.5124 1.3912 1.3181 8.81%
Price Multiplier on Financial Quarter End Date
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Date 29/12/17 30/12/16 31/12/15 31/12/14 31/12/13 31/12/12 30/12/11 -
Price 3.90 4.00 5.13 3.96 6.87 3.33 2.09 -
P/RPS 2.61 2.77 3.08 2.44 1.62 0.91 0.68 25.10%
P/EPS 19.47 25.40 22.81 18.49 13.07 8.04 5.74 22.55%
EY 5.14 3.94 4.38 5.41 7.65 12.43 17.43 -18.39%
DY 2.05 1.58 0.88 2.15 2.47 5.11 7.18 -18.83%
P/NAPS 1.78 1.94 2.73 2.28 1.41 0.73 0.49 23.96%
Price Multiplier on Announcement Date
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Date 23/02/18 24/02/17 29/02/16 25/02/15 26/02/14 27/02/13 28/02/12 -
Price 4.37 4.10 5.00 4.29 7.51 3.01 2.51 -
P/RPS 2.92 2.84 3.00 2.65 1.77 0.82 0.82 23.55%
P/EPS 21.81 26.04 22.24 20.03 14.29 7.27 6.89 21.15%
EY 4.58 3.84 4.50 4.99 7.00 13.75 14.51 -17.47%
DY 1.83 1.54 0.90 1.98 2.26 5.65 5.98 -17.89%
P/NAPS 2.00 1.99 2.66 2.47 1.54 0.66 0.58 22.89%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment